Search results

Page results

• Dangoor Family’s Exilarch’s Foundation gift to speed up pioneering cancer care at UCLH

  UCLH Charity is delighted to announce that the Dangoor Family’s Exilarch’s Foundation has pledged a £1.2m gift to support the next phase of the development of the CAR T programme at University College London Hospitals NHS Foundation Trust (UCLH). The CAR T Speed Release Project aims to reduce the time between extracting patient’s stem cells and injecting re-engineered CAR T cells back into patients with cancer to fight cancer cells.

• Publications and Reading Material

  The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements. 

• Immunotherapy significantly increases the number of patients free from bowel cancer

  An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

• King’s Coronation Medal awarded to our head of operations

  Alison Clements, head of operations, patient flow and EPRR, has received a medal in recognition of her work to support NHS preparations for the Coronation of Charles III and Camilla last May.

• What is acute myeloid leukaemia (AML)?

  Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.

• Navigating the exam period

  The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.

• UCLH recruits first participant internationally for new trial in Frontotemporal dementia

  UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.

• Treating acute myeloid leukaemia (AML)

  Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.

• What is acute lymphoblastic leukaemia (ALL)

  Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.

• Treating acute lymphoblastic leukaemia (ALL)

  Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.